Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2019 | Story Valentino Ndaba
Be Safe on road
Be safe on the roads: Prevention is better than a hospital ward or coffin.

Safety starts with you, non-compliance ends you. A traffic spike over the Easter holidays does not justify disobeying road rules. The university is counting on all students, both drivers and pedestrians, to continue prioritising safety on the roads.

Don’t be a statistic, take responsibility
The 2018 Preliminary Easter Road Safety Report issued by the Department of Transport, indicated that most accidents were caused by irresponsibility.  “In 2018, human factor contributed 89,5% to crashes as compared to the 74,3% in 2017. The number of jay-walking pedestrians killed on our roads also increased to 38% as compared to 25,2% in 2017,” said Minister of Transport, Blade Nzimande.

The university implores you to play a role in reducing these numbers in 2019.

On driving and cellphones
According to Arrive Alive, the use of communication devices while driving is prohibited. “No person shall drive a vehicle on a public road while holding a cellular or mobile telephone or any other communication device in one or both hands or with any other part of the body, unless such a device is affixed to the vehicle or is part of the fixture in the vehicle.”

Pedestrian duties
Pedestrians are encouraged to practice caution when using sidewalks and while crossing the road. When walking, face oncoming traffic and pay attention to traffic signs so as not to constitute a source of danger to yourself or to traffic.

Safe speed saves lives
A general speed limit of 60 kilometres per hour shall apply to all public roads within urban areas, 100 kilometres per hour on public roads, and 120 kilometres per hour on freeways. Abide by these speed limits, unless stated otherwise by traffic signs.

More tips on drunken driving, wearing seat belts, and other aspects of road safety are easily available on the Arrive Alive website.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept